{"id":"cd10367-1-solution-non-desquamated-zone","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"CD10367 1% solution is a dermatological agent in Phase 2 development by Galderma R&D. The specific mechanism of action is not publicly disclosed, but given its topical formulation and indication for non-desquamated zones, it likely works through local anti-inflammatory, antimicrobial, or tissue-remodeling pathways. The designation of 'non-desquamated zone' suggests it targets lesions without significant scaling.","oneSentence":"CD10367 is a topical solution designed to treat non-desquamated (non-scaling) skin lesions, likely through anti-inflammatory or keratolytic activity.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T03:50:10.762Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Non-desquamated skin lesions (Phase 2)"}]},"trialDetails":[{"nctId":"NCT03025282","phase":"PHASE2","title":"Safety and Efficacy of CD10367 in Psoriasis Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2016-11-03","conditions":"Psoriasis Vulgaris","enrollment":24}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"CD10367 1% Solution - Non-desquamated zone","genericName":"CD10367 1% Solution - Non-desquamated zone","companyName":"Galderma R&D","companyId":"galderma-r-d","modality":"Small molecule","firstApprovalDate":"","aiSummary":"CD10367 is a topical solution designed to treat non-desquamated (non-scaling) skin lesions, likely through anti-inflammatory or keratolytic activity. Used for Non-desquamated skin lesions (Phase 2).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}